Champions Oncology, Inc.
CSBR · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $4,701 | -$7,276 | -$5,335 | $548 |
| Dep. & Amort. | $1,640 | $1,867 | $2,246 | $1,627 |
| Deferred Tax | $0 | $0 | $1,002 | $0 |
| Stock-Based Comp. | $654 | $1,118 | $864 | $912 |
| Change in WC | -$621 | -$3,823 | $4,226 | $2,336 |
| Other Non-Cash | $1,012 | $1,977 | $952 | $1,074 |
| Operating Cash Flow | $7,386 | -$6,137 | $3,955 | $6,497 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$389 | -$836 | -$2,872 | -$2,384 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$389 | -$836 | -$2,872 | -$2,384 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$150 | -$146 | $0 | $0 |
| Stock Issued | $320 | $0 | $0 | $207 |
| Stock Repurch. | $0 | -$634 | -$74 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $253 | $85 | $0 |
| Financing Cash Flow | $170 | -$527 | $11 | $207 |
| Forex Effect | $0 | $0 | $17 | $0 |
| Net Chg. in Cash | $7,167 | -$7,500 | $1,111 | $4,320 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $2,618 | $10,118 | $9,007 | $4,687 |
| End Cash | $9,785 | $2,618 | $10,101 | $9,007 |
| Free Cash Flow | $6,997 | -$6,973 | $1,083 | $4,113 |